Procter & Gamble Health Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Procter & Gamble Health Quarterly Results    (EMER)

Here are the latest quarterly results of Procter & Gamble Health. For more details, see the Procter & Gamble Health financial fact sheet and Procter & Gamble Health share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Procter & Gamble Health Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,2612,0442,3102,3362,2522,3682,2816,345 
Other income Rs m6172177175676110396 
Turnover Rs m2,3222,1162,4872,5112,3192,4282,3846,441 
Expenses Rs m1,6801,8901,8091,7911,7531,8771,6945,242 
Gross profit Rs m5821535015454994905871,103 
Depreciation Rs m43464345404342132 
Interest Rs m000000010 
Profit before tax Rs m5991796356755265086481,056 
Tax Rs m18844228234168126183364 
Profit after tax Rs m411135407441358382465692 
Gross profit margin %25.77.521.723.322.220.725.817.4 
Effective tax rate %31.424.635.934.732.024.828.334.5 
Net profit margin %18.26.617.618.915.916.120.410.9 
Diluted EPS Rs 24.8 8.1 24.5 26.6 21.5 23.0 28.0 41.7  
Diluted EPS (TTM) Rs 64.4 66.3 77.2 84.0 80.7 95.6 99.1 114.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Procter & Gamble Health 1QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SUN PHARMA  PIRAMAL ENTERPRISES  IPCA LABS  UNICHEM LAB  PANACEA BIOTECH  

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA  PIRAMAL ENTERPRISES  IPCA LABS  UNICHEM LAB  PANACEA BIOTECH  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and Telecom Stocks Witness Buying(Closing)

Indian share markets erased gains during the last hour of trading in today's volatile session, but still ended marginally higher.

Views on news

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

How to Shortlist the Best Stocks for Trading (Fast Profits Daily)

Oct 7, 2020

In this video, I'll show you how to identify a confluence of factors in the market which will point you to the best stocks to trade.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Oct 20, 2020 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - MYLAN COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS